APOH and ischemic stroke: When we compared patients with certain aPL for differences in their NPSLE manifestations we found that patients with anti-β2GPI IgM have an almost six times higher likelihood of having nonspecific, intractable headaches (Table 4) or ischemic stroke (Table 5) than patients negative for these antibodies.